The temporal context of oral anticoagulation outcome in atrial fibrillation
- PMID: 35663453
- PMCID: PMC9157463
- DOI: 10.1016/j.ijcha.2022.101051
The temporal context of oral anticoagulation outcome in atrial fibrillation
Similar articles
-
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED).Ann Emerg Med. 2019 Apr;73(4):382-392. doi: 10.1016/j.annemergmed.2018.09.001. Epub 2018 Oct 26. Ann Emerg Med. 2019. PMID: 30502307 Clinical Trial.
-
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Rev Neurol (Paris). 2015. PMID: 25912470 Review.
-
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4. Lancet. 2006. PMID: 16765759 Clinical Trial.
-
Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation.J Neurol Sci. 2013 Nov 15;334(1-2):139-42. doi: 10.1016/j.jns.2013.08.013. Epub 2013 Aug 15. J Neurol Sci. 2013. PMID: 24054537
-
[Anticoagulation with atrial fibrillation].Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):89-94. doi: 10.1007/s00399-006-0515-z. Herzschrittmacherther Elektrophysiol. 2006. PMID: 16786467 Review. German.
Cited by
-
Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation.Int J Cardiol Heart Vasc. 2023 Aug 21;48:101259. doi: 10.1016/j.ijcha.2023.101259. eCollection 2023 Oct. Int J Cardiol Heart Vasc. 2023. PMID: 37663614 Free PMC article. No abstract available.
References
-
- Teppo K., Jaakkola J., Airaksinen K.E.J., Biancari F., Halminen O., Putaala J., Mustonen P., Haukka J., Hartikainen J., Luojus A., Niemi M., Linna M., Lehto M. Mental Health Conditions and Nonpersistence of Direct Oral Anticoagulant Use in Patients With Incident Atrial Fibrillation: A Nationwide Cohort Study. J. Am. Heart Assoc. 2022;11:e024119. - PMC - PubMed
-
- Kozieł M., Mazurek M., Teutsch C., Diener H.-C., Dubner S.J., Halperin J.L., Ma C.-S., Rothman K.J., Brandes A., Paquette M., Zint K., França L.R., Lu S., Bartels D.B., Huisman M.V., Lip G.Y.H. Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up. J. Clin. Med. 2020;9(6):1969. doi: 10.3390/jcm9061969. - DOI - PMC - PubMed
-
- Douros A., Renoux C., Coulombe J., Suissa S. Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study. Pharmacoepidemiol. Drug Saf. 2017;26(12):1546–1554. - PubMed
-
- Gopalakrishnan C., Schneeweiss S., Bartels D.B., Zint K., Santiago Ortiz A., Huybrechts K.F. Evaluating utilization patterns of oral anticoagulants in routine care. J. Thromb. Haemost. 2019;17(7):1033–1043. - PubMed
Publication types
LinkOut - more resources
Full Text Sources